BackFulgent Genetics Overview

Fulgent Genetics Receivables

Track Fulgent Genetics's receivables ($62M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$62.49M
↓ 12.21% YoYΔ $-8.69M vs prior year quarter

Peer trimmed avg / median

Loading

Fulgent Genetics Receivables History

Loading

Fulgent Genetics vs. peers: Receivables Comparison

Loading

Fulgent Genetics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fulgent Genetics (FLGT) FAQ

Fulgent Genetics (FLGT) currently reports a receivables of $62M as of September 2026. That compares with $71M in the prior-year period — down 12.2% year over year. Use the charts on this page to explore Fulgent Genetics's receivables history and peer comparisons.

Fulgent Genetics's receivables decreased from $71M to $62M — a 12.2% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fulgent Genetics reported $62M in receivables as of September 2026. That compares with $71M in the prior-year period — down 12.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $62M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fulgent Genetics, and consider following FLGT for alerts when major investors trade the stock.

Fulgent Genetics is classified in the Healthcare sector. On receivables, it currently shows $62M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FLGT with unrelated industries.